Study author Sun H Kim, MD, MS, Associate Professor of Medicine in the Division of Endocrinology, Gerontology, and Metabolism at Stanford, summarized the findings to to Medical News Today , saying: We found that semaglutide compared to other weight loss medications, including another GLP-1 medication called dulaglutide, reduced risk of future fractures despite being associated with greater weight loss. Overall, semaglutide was linked to a bigger decrease in BMI
J.Veenstra-VanderWeeleJ
McClain was admitted to the hospital after injecting nearly nine times the amount of semaglutide that patients typically take as a first dose of the popular weight loss drug
PubMed laboratory research record [PMID: 42335260] PubMed record related to this compound for laboratory literature review
At Klinic, we're committed to providing accessible, efficient, and personalized care for your weight loss journey
Retrieved 27 July 2026